S&P 500   3,324.84 (+0.55%)
DOW   27,158.50 (+1.23%)
QQQ   270.97 (+0.22%)
AAPL   438.26 (-0.09%)
MSFT   213.03 (-0.12%)
FB   250.86 (+0.41%)
GOOGL   1,485.78 (+0.85%)
AMZN   3,187.85 (+1.56%)
NVDA   452.31 (+0.71%)
CGC   19.03 (-1.50%)
BABA   263.37 (+0.45%)
TSLA   1,483.63 (-0.23%)
MU   51.26 (-0.08%)
GE   6.17 (+0.49%)
AMD   85.32 (+0.33%)
T   29.88 (-0.43%)
F   6.97 (+1.60%)
ACB   10.62 (-1.03%)
GILD   69.47 (-1.99%)
NFLX   505.22 (-0.87%)
DIS   130.06 (+10.89%)
BAC   25.44 (+1.72%)
BA   171.10 (+3.65%)
S&P 500   3,324.84 (+0.55%)
DOW   27,158.50 (+1.23%)
QQQ   270.97 (+0.22%)
AAPL   438.26 (-0.09%)
MSFT   213.03 (-0.12%)
FB   250.86 (+0.41%)
GOOGL   1,485.78 (+0.85%)
AMZN   3,187.85 (+1.56%)
NVDA   452.31 (+0.71%)
CGC   19.03 (-1.50%)
BABA   263.37 (+0.45%)
TSLA   1,483.63 (-0.23%)
MU   51.26 (-0.08%)
GE   6.17 (+0.49%)
AMD   85.32 (+0.33%)
T   29.88 (-0.43%)
F   6.97 (+1.60%)
ACB   10.62 (-1.03%)
GILD   69.47 (-1.99%)
NFLX   505.22 (-0.87%)
DIS   130.06 (+10.89%)
BAC   25.44 (+1.72%)
BA   171.10 (+3.65%)
S&P 500   3,324.84 (+0.55%)
DOW   27,158.50 (+1.23%)
QQQ   270.97 (+0.22%)
AAPL   438.26 (-0.09%)
MSFT   213.03 (-0.12%)
FB   250.86 (+0.41%)
GOOGL   1,485.78 (+0.85%)
AMZN   3,187.85 (+1.56%)
NVDA   452.31 (+0.71%)
CGC   19.03 (-1.50%)
BABA   263.37 (+0.45%)
TSLA   1,483.63 (-0.23%)
MU   51.26 (-0.08%)
GE   6.17 (+0.49%)
AMD   85.32 (+0.33%)
T   29.88 (-0.43%)
F   6.97 (+1.60%)
ACB   10.62 (-1.03%)
GILD   69.47 (-1.99%)
NFLX   505.22 (-0.87%)
DIS   130.06 (+10.89%)
BAC   25.44 (+1.72%)
BA   171.10 (+3.65%)
S&P 500   3,324.84 (+0.55%)
DOW   27,158.50 (+1.23%)
QQQ   270.97 (+0.22%)
AAPL   438.26 (-0.09%)
MSFT   213.03 (-0.12%)
FB   250.86 (+0.41%)
GOOGL   1,485.78 (+0.85%)
AMZN   3,187.85 (+1.56%)
NVDA   452.31 (+0.71%)
CGC   19.03 (-1.50%)
BABA   263.37 (+0.45%)
TSLA   1,483.63 (-0.23%)
MU   51.26 (-0.08%)
GE   6.17 (+0.49%)
AMD   85.32 (+0.33%)
T   29.88 (-0.43%)
F   6.97 (+1.60%)
ACB   10.62 (-1.03%)
GILD   69.47 (-1.99%)
NFLX   505.22 (-0.87%)
DIS   130.06 (+10.89%)
BAC   25.44 (+1.72%)
BA   171.10 (+3.65%)
Log in

NASDAQ:RTIXRTI Surgical Stock Price, Forecast & News

$3.14
0.00 (0.00 %)
(As of 07/22/2020)
Add
Compare
Today's Range
$3.12
Now: $3.14
$3.30
50-Day Range
$2.70
MA: $3.12
$4.55
52-Week Range
$1.46
Now: $3.14
$5.40
Volume686,036 shs
Average Volume823,396 shs
Market Capitalization$234.24 million
P/E RatioN/A
Dividend YieldN/A
Beta2.14
RTI Surgical Holdings, Inc., a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company's implants are used in the fields of orthopedic, spine, sports medicine, general surgery, trauma and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force, as well as through a network of independent distributors. RTI Surgical Holdings, Inc. was founded in 1997 and is based in Deerfield, Illinois.
Read More
RTI Surgical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.47 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:RTIX
CUSIP74975N10
Phone386-418-8888

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$308.38 million
Cash Flow$0.30 per share
Book Value$2.89 per share

Profitability

Net Income$-211,640,000.00

Miscellaneous

Employees891
Market Cap$234.24 million
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable
$3.14
0.00 (0.00 %)
(As of 07/22/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive RTIX News and Ratings via Email

Sign-up to receive the latest news and ratings for RTIX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











RTI Surgical (NASDAQ:RTIX) Frequently Asked Questions

How has RTI Surgical's stock been impacted by COVID-19 (Coronavirus)?

RTI Surgical's stock was trading at $3.09 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RTIX shares have increased by 1.6% and is now trading at $3.14.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of RTI Surgical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RTI Surgical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for RTI Surgical
.

When is RTI Surgical's next earnings date?

RTI Surgical is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020.
View our earnings forecast for RTI Surgical
.

How were RTI Surgical's earnings last quarter?

RTI Surgical Holdings Inc (NASDAQ:RTIX) announced its quarterly earnings data on Monday, June, 8th. The medical equipment provider reported ($0.16) earnings per share for the quarter. The medical equipment provider had revenue of $80.21 million for the quarter.
View RTI Surgical's earnings history
.

What price target have analysts set for RTIX?

2 brokers have issued 1-year price objectives for RTI Surgical's stock. Their forecasts range from $5.00 to $5.00. On average, they anticipate RTI Surgical's stock price to reach $5.00 in the next year. This suggests a possible upside of 59.2% from the stock's current price.
View analysts' price targets for RTI Surgical
.

Has RTI Surgical been receiving favorable news coverage?

News coverage about RTIX stock has trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. RTI Surgical earned a coverage optimism score of -1.0 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the stock's share price in the next several days.
View the latest news about RTI Surgical
.

Are investors shorting RTI Surgical?

RTI Surgical saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 966,500 shares, an increase of 21.5% from the June 15th total of 795,500 shares. Based on an average daily trading volume, of 577,100 shares, the short-interest ratio is presently 1.7 days. Currently, 1.4% of the shares of the company are sold short.
View RTI Surgical's Current Options Chain
.

Who are some of RTI Surgical's key competitors?

What other stocks do shareholders of RTI Surgical own?

Who are RTI Surgical's key executives?

RTI Surgical's management team includes the following people:
  • Mr. Camille I. Farhat, CEO, Pres & Director (Age 49)
  • Mr. Jonathon M. Singer, Chief Financial & Admin. Officer and Corp. Sec. (Age 55)
  • Mr. John N. Varela, Exec. VP of Global Operations (Age 52)
  • Mr. Tony Lemus, VP of Global R&D, Clinical and Regulatory
  • Ms. Molly Poarch, Director of Corp. Communications

What is RTI Surgical's stock symbol?

RTI Surgical trades on the NASDAQ under the ticker symbol "RTIX."

Who are RTI Surgical's major shareholders?

RTI Surgical's stock is owned by a number of retail and institutional investors. Top institutional investors include Paradigm Capital Management Inc. NY (6.57%), UBS Group AG (0.18%), Dfpg Investments LLC (0.14%), Strs Ohio (0.11%), Assenagon Asset Management S.A. (0.11%) and Dupont Capital Management Corp (0.11%). Company insiders that own RTI Surgical stock include Camille Farhat and Jonathon M Singer.
View institutional ownership trends for RTI Surgical
.

Which major investors are selling RTI Surgical stock?

RTIX stock was sold by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY, and UBS Group AG.
View insider buying and selling activity for RTI Surgical
.

Which major investors are buying RTI Surgical stock?

RTIX stock was acquired by a variety of institutional investors in the last quarter, including Dfpg Investments LLC, Assenagon Asset Management S.A., Dupont Capital Management Corp, Mackay Shields LLC, Chicago Partners Investment Group LLC, SG Americas Securities LLC, and Strs Ohio. Company insiders that have bought RTI Surgical stock in the last two years include Camille Farhat, and Jonathon M Singer.
View insider buying and selling activity for RTI Surgical
.

How do I buy shares of RTI Surgical?

Shares of RTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is RTI Surgical's stock price today?

One share of RTIX stock can currently be purchased for approximately $3.14.

How big of a company is RTI Surgical?

RTI Surgical has a market capitalization of $234.24 million and generates $308.38 million in revenue each year. The medical equipment provider earns $-211,640,000.00 in net income (profit) each year or ($0.16) on an earnings per share basis. RTI Surgical employs 891 workers across the globe.

What is RTI Surgical's official website?

The official website for RTI Surgical is www.rtix.com.

How can I contact RTI Surgical?

RTI Surgical's mailing address is 11621 RESEARCH CIRCLE, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-418-8888 or via email at [email protected]

This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.